Sapporo Clinical Laboratory Inc. (9776.T)
JPY 975.0
(0.83%)
JPY 975.0
(0.83%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 19.68 Billion | 20.12 Billion | 19.1 Billion | 17.5 Billion | 17.65 Billion |
| Cost of Revenue | 13.78 Billion | 13.82 Billion | 12.78 Billion | 11.76 Billion | 12.25 Billion |
| Gross Profit | 5.89 Billion | 6.29 Billion | 6.32 Billion | 5.73 Billion | 5.4 Billion |
| Operating Expenses | 5.36 Billion | 5.28 Billion | 4.78 Billion | 4.59 Billion | 4.45 Billion |
| Selling, General and Administrative Expenses | 131.58 Million | 138.93 Million | 141.65 Million | 125.03 Million | 3.89 Billion |
| Research and Development Expenses | - | 9 Million | 10 Million | 8 Million | 9.3 Million |
| Other Expenses | 5.22 Billion | 147.57 Million | 65.74 Million | 41.87 Million | -551.83 Million |
| Cost and Expenses | 19.14 Billion | 19.11 Billion | 17.57 Billion | 16.36 Billion | 16.71 Billion |
| Operating Income | 534.5 Million | 1 Billion | 1.53 Billion | 1.14 Billion | 945.95 Million |
| Interest Expense | 7.49 Million | 8.16 Million | 9.02 Million | 2.57 Million | 2.17 Million |
| Income Tax Expense | 234.99 Million | 319.14 Million | 455.6 Million | 382.23 Million | 317.05 Million |
| Earnings before Tax | 597.94 Million | 959.69 Million | 1.5 Billion | 1.17 Billion | 845.25 Million |
| Net Income | 380.15 Million | 568.61 Million | 1.04 Billion | 793.68 Million | 528.2 Million |
| Earnings Per Share Basic | 114.16 | 170.53 | 306.16 | 231.85 | 154.31 |
| Earnings Per Share Diluted | 114.16 | 170.53 | 306.16 | 231.85 | 154.31 |
| Weighted Average Shares Outstanding | 3.33 Million | 3.33 Million | 3.4 Million | 3.42 Million | 3.42 Million |
| Weighted Average Shares Outstanding (Diluted) | 3.33 Million | 3.33 Million | 3.4 Million | 3.42 Million | 3.42 Million |
| Gross Margin | 0.30 | 0.31 | 0.33 | 0.33 | 0.31 |
| EBIT Margin | 0.06 | 0.08 | 0.11 | 0.08 | 0.07 |
| Profit Margin | 0.02 | 0.03 | 0.05 | 0.05 | 0.03 |
| EBITDA | 1.14 Billion | 1.48 Billion | 2.05 Billion | 1.44 Billion | 1.09 Billion |
| Earnings Before Tax Margin | 0.03 | 0.05 | 0.08 | 0.07 | 0.05 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 4.99 Billion | 4.82 Billion | 19.68 Billion | 4.99 Billion | 4.93 Billion | 4.92 Billion |
| Cost of Revenue | 3.55 Billion | 3.38 Billion | 13.78 Billion | 3.49 Billion | 3.38 Billion | 3.52 Billion |
| Gross Profit | 1.44 Billion | 1.44 Billion | 5.89 Billion | 1.49 Billion | 1.55 Billion | 1.39 Billion |
| Operating Expenses | 1.34 Billion | 1.32 Billion | 5.36 Billion | 1.37 Billion | 1.34 Billion | 1.32 Billion |
| Selling, General and Administrative Expenses | 1.34 Billion | 522 Million | - | 1.37 Billion | 1.34 Billion | 1.32 Billion |
| Research and Development Expenses | - | 9 Million | - | 3 Million | 2 Million | 2 Million |
| Other Expenses | 1 Million | 2.67 Million | 6.38 Million | -2.14 Million | 1.63 Million | 4.22 Million |
| Cost and Expenses | 4.9 Billion | 4.7 Billion | 19.14 Billion | 4.86 Billion | 4.72 Billion | 4.84 Billion |
| Operating Income | 98 Million | 119.86 Million | 534.5 Million | 123.33 Million | 215.63 Million | 75.66 Million |
| Interest Expense | - | 1.88 Million | 7.49 Million | 1.9 Million | 1.87 Million | 1.82 Million |
| Income Tax Expense | 42 Million | 31.54 Million | 234.99 Million | 43.11 Million | 95.46 Million | 64.87 Million |
| Earnings before Tax | 102 Million | 89.93 Million | 597.94 Million | 121.59 Million | 312.35 Million | 74.06 Million |
| Net Income | 56 Million | 68.18 Million | 380.15 Million | 85.67 Million | 220.58 Million | 5.71 Million |
| Earnings Per Share Basic | 17.74 | 20.72 | - | 25.53 | 66.37 | 1.72 |
| Earnings Per Share Diluted | 17.74 | 20.72 | - | 25.53 | 66.37 | 1.72 |
| Weighted Average Shares Outstanding | 3.15 Million | 3.33 Million | 3.33 Million | 3.33 Million | 3.33 Million | 3.33 Million |
| Weighted Average Shares Outstanding (Diluted) | 3.15 Million | 3.33 Million | 3.33 Million | 3.33 Million | 3.33 Million | 3.33 Million |
| Gross Margin | 0.29 | 0.30 | 0.30 | 0.30 | 0.32 | 0.28 |
| EBIT Margin | 0.05 | 0.03 | - | 0.02 | 0.04 | 0.02 |
| Profit Margin | 0.01 | 0.01 | 0.02 | 0.02 | 0.04 | 0.00 |
| EBITDA | 232.75 Million | 122.96 Million | - | 123.43 Million | 217.34 Million | 82.7 Million |
| Earnings Before Tax Margin | 0.02 | 0.02 | 0.03 | 0.02 | 0.04 | 0.02 |
CGO
PDSSF
MACI
600757
5283
0008